Feb 5, 2026 04:05PM
Feb 2, 2026 04:05PM
Feb 2, 2026 04:05PM
Jan 29, 2026 11:33PM
Jan 29, 2026 11:33PM
Jan 29, 2026 04:07PM
Jan 29, 2026 04:06PM Vaxcyte Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded Warrants
Nov 4, 2025 04:05PM
Nov 4, 2025 04:05PM
Aug 8, 2025 08:34AM
Mar 31, 2025 08:05AM
Jan 30, 2025 04:05PM
Nov 5, 2024 04:01PM
Sep 6, 2024 04:06PM Vaxcyte, Inc (PCVX) Closes $1.5B Offering
Sep 6, 2024 04:05PM
Sep 5, 2024 06:13AM
Sep 4, 2024 11:58PM
Sep 3, 2024 04:02PM
Sep 3, 2024 04:01PM
Feb 2, 2024 06:39PM
Feb 1, 2024 04:05PM Vaxcyte to Present at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference
Jan 31, 2024 04:26AM
Jan 30, 2024 11:37PM
Jan 30, 2024 04:02PM
Jan 30, 2024 04:01PM
Oct 31, 2023 04:05PM
Apr 21, 2023 05:25PM
Apr 21, 2023 05:25PM Vaxcyte Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Apr 19, 2023 05:40AM
Apr 19, 2023 12:26AM
Apr 19, 2023 12:26AM
Apr 17, 2023 04:06PM
Apr 17, 2023 04:05PM
Apr 17, 2023 04:05PM
Nov 3, 2022 08:30AM Vaxcyte to Present at Upcoming Investor Conferences
Nov 3, 2022 08:30AM
Oct 28, 2022 04:01PM
Oct 28, 2022 04:01PM
Oct 26, 2022 03:29AM
Oct 26, 2022 12:20AM
Oct 26, 2022 12:20AM
Oct 24, 2022 04:01PM Vaxcyte (PCVX) Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded Warrants
Oct 24, 2022 04:01PM
Oct 24, 2022 04:01PM
Sep 28, 2021 04:05PM
Sep 28, 2021 04:05PM

22,829 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All